Are sleep studies helpful in children with Prader-Willi syndrome prior to commencement of growth hormone therapy?

Journal of Paediatrics and Child Health

Volumn 49, Issue 3, 2013, Pages 238-241

  Vandeleur, Moya ^a   Davey, Margot J ^a   Nixon, Gillian M ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

growth hormone; obstructive sleep apnoea; polysomnography; Prader Willi syndrome; sleep study

Indexed keywords

GROWTH HORMONE;

ADENOTONSILLECTOMY; ADOLESCENT; APNEA HYPOPNEA INDEX; ARTICLE; BODY MASS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DATA BASE; HORMONAL THERAPY; HUMAN; MEDICAL RECORD REVIEW; NONINVASIVE VENTILATION; OUTCOME ASSESSMENT; POLYSOMNOGRAPHY; PRADER WILLI SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SLEEP DISORDERED BREATHING; SYMPTOM ASSESSMENT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HUMAN GROWTH HORMONE; HUMANS; INFANT; POLYSOMNOGRAPHY; PRADER-WILLI SYNDROME; RETROSPECTIVE STUDIES; SLEEP; SLEEP APNEA, OBSTRUCTIVE;

EID: 84874983035     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.12109     Document Type: Article

References (23)

1. Arens R, Gozal D, Omlin KJ, et al. Hypoxic and hypercapnic ventilatory responses in Prader-Willi syndrome. J. Appl. Physiol. 1994; 77: 2224-2230.
2. Holm VA, Cassidy SB, Butler MG, et al. Prader-Willi syndrome: consensus diagnostic criteria. Paediatrics 1993; 91: 398-402.
3. Schluter B, Buschatz D, Trowitzsch E, Aksu F, Andler W,. Respiratory control in children with Prader-Willi syndrome. Eur. J. Pediatr. 1997; 156: 65-68.
4. Lin H-Y, Lin S-P, Lin C-C, et al. Polysomnographic characteristics in patients with Prader-Willi syndrome. Pediatr. Pulmonol. 2007; 42: 881-887.
5. Carrel AL, Myers SE, Whitman BY, Allen DB,. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: a controlled study. J. Pediatr. 1999; 134: 215-221.
6. Festen DAM, de Weerd AW, van den Bossche RAS, Joosten K, Hoeve H, Hokken-Koelega ACS,. Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment. J. Clin. Endocrinol. Metab. 2006; 91: 4911-4915.
7. Lindgren AC, Hellstrom LG, Ritzen EM, Milerad J,. Growth hormone treatment increases CO(2) response, ventilation and central inspiratory drive in children with Prader-Willi syndrome. Eur. J. Pediatr. 1999; 158: 936-940.
8. Haqq AM, Stadler DD, Jackson RH, Rosenfeld RG, Purnell JQ, LaFranchi SH,. Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 2003; 88: 2206-2212.
9. Tauber M, Diene G, Molinas C, Hebert M,. Review of 64 cases of death in children with Prader-Willi syndrome (PWS). Am. J. Med. Genet. A 2008; 146: 881-887.
10. Schrander-Stumpel CTRM, Curfs LMG, Sastrowijoto P, Cassidy SB, Schrander JJP, Fryns J-P,. Prader-Willi syndrome: causes of death in an international series of 27 cases. Am. J. Med. Genet. A 2004; 124: 333-338.
11. Nagai T, Obata K, Tonoki H, et al. Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment. Am. J. Med. Genet. A 2005; 136: 45-48.
12. Riedl S, Blumel P, Zwiauer K, Frisch H,. Death in two female Prader-Willi syndrome patients during the early phase of growth hormone treatment. Acta Paediatr. 2005; 94: 974-977.
13. Grugni G, Livieri C, Corrias A, Sartorio A, Crino A, Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and D. Death during GH therapy in children with Prader-Willi syndrome: description of two new cases. J. Endocrinol. Invest. 2005; 28: 554-557.
14. Van Vliet G, Deal CL, Crock PA, Robitaille Y, Oligny LL,. Sudden death in growth hormone-treated children with Prader-Willi syndrome. J. Pediatr. 2004; 144: 129-131.
15. Australian Government Department of Health and Aging. Guidelines for the Pharmaceutical Benefits Scheme Growth Hormone Program (April 2012), 2012. Available from: http://www.health.gov.au/hgh. [accessed 22 November 2011].
16. USDA/ARS Children's Nutrition Research Centre. Children's BMI-percentile-for-age Calculator, 2007. Available from: http://www.bcm.edu/ cnrc/bodycomp/bmiz2.html. [accessed 17 January 2011].
17. American Thoracic Society. Standards and indications for cardiopulmonary sleep studies in children. Am. J. Respir. Crit. Care Med. 1996; 153: 866-878.
18. Katz ES, Greene MG, Carson KA, et al. Night-to-night variability of polysomnography in children with suspected obstructive sleep apnea. J. Pediatr. 2002; 140: 589-594.
19. Nixon GM, Brouillette RT,. Sleep and breathing in Prader-Willi syndrome. Pediatr. Pulmonol. 2002; 34: 209-217.
20. Miller J, Silverstein J, Shuster J, Driscoll DJ, Wagner M,. Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 2006; 91: 413-417.
21. Brunetti L, Rana S, Lospalluti ML, et al. Prevalence of obstructive sleep apnea syndrome in a cohort of 1,207 children of southern Italy. Chest 2001; 120: 1930-1935.
22. Fillion M, Deal C, Van Vliet G,. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome. J. Pediatr. 2009; 154: 230-233.
23. Nixon GM, Rodda CP, Davey MJ,. Longitudinal association between growth hormone therapy and obstructive sleep apnea in a child with Prader-Willi syndrome. J. Clin. Endocrinol. Metab. [Case Reports] 2011; 96: 29-33.